Peer-reviewedCC BY-NC 4.0Journal of Alzheimer's Disease
New mouse models for Down syndrome Alzheimer's disease
- 1UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK
Abstract
In this issue Ishihara and colleagues report the development and characterization of new mouse models for Down syndrome Alzheimer's disease, the most commonly occurring genetic cause of dementia worldwide. These new models add to the growing portfolio of in vivo models of Down syndrome. In particular, the new Ts1Kei-APPswe/PS1dE9 model may be highly useful for the study and identification of novel treatment targets for late onset myoclonic epilepsy of Down syndrome. This seizure disorder is a common comorbidity of Down syndrome Alzheimer's disease affecting around half of all people with the condition and is associated with particularly adverse clinical outcomes.
Related
- Characterising patients in England with Down syndrome and Alzheimer's disease: a descriptive observational study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics.
- Tau extent is associated with lower cognition in Down syndrome‐related Alzheimer's disease
- HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
- Reduced cerebral blood flow and metabolic rate trigger an adaptive mitochondrial remodeling program in a Down syndrome mouse model
- Delayed presentation of type I jejunal atresia radiologically mimicking malrotation in an infant with Down syndrome and congenital heart disease: a case report
BibTeX
@article{wiseman2026mouse,
title = {{New mouse models for Down syndrome Alzheimer's disease}},
author = {Frances K. Wiseman},
journal = {Journal of Alzheimer's Disease},
year = {2026},
month = sep,
doi = {10.1177/13872877261488873},
url = {https://doi.org/10.1177/13872877261488873},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - New mouse models for Down syndrome Alzheimer's disease
AU - Frances K. Wiseman
PY - 2026
DA - 2026/09/17
JO - Journal of Alzheimer's Disease
DO - 10.1177/13872877261488873
UR - https://doi.org/10.1177/13872877261488873
AB - In this issue Ishihara and colleagues report the development and characterization of new mouse models for Down syndrome Alzheimer's disease, the most commonly occurring genetic cause of dementia worldwide. These new models add to the growing portfolio of in vivo models of Down syndrome. In particular, the new Ts1Kei-APPswe/PS1dE9 model may be highly useful for the study and identification of novel treatment targets for late onset myoclonic epilepsy of Down syndrome. This seizure disorder is a common comorbidity of Down syndrome Alzheimer's disease affecting around half of all people with the condition and is associated with particularly adverse clinical outcomes.
SN - 1387-2877
SN - 1875-8908
ER -